Briefing paper on Value Based Pricing and Cancer Drugs Fund

20 Sep 2013

On 20th September 2013, Cancer52 published Briefing Papers on Value Based Pricing (VBP) and the Cancer Drugs Fund (CDF); alongside an introductory debate on the topic among leading experts from within the Cancer52 family.

Please reload

  • Twitter
  • Facebook

Terms & conditions  Cookie policy   Privacy policy

Copyright © Cancer52. All rights reserved.

Cancer52 is registered as a charity in England and Wales (1174569) and a company limited by guarantee in England and Wales (7994413)